Clinical trial
Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent…
NCT00171990 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171990 |
|---|---|
| Title | Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes |
| Official title | Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Recurrent Genital Herpes |
| Intervention type | Drug |
| Interventions | Famciclovir |
| Enrollment | 1,461 |
| Start date | Jan 1, 2003 |
| Completion | Feb 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 15, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: